NeuroOne Medical Technologies Corporation
NMTC
$0.75
$0.011.91%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.62M | -1.50M | -2.27M | 1.79M | -3.35M |
| Total Depreciation and Amortization | 64.30K | 66.60K | 65.60K | 65.10K | 64.10K |
| Total Amortization of Deferred Charges | -192.60K | 0.00 | 0.00 | 192.60K | -- |
| Total Other Non-Cash Items | 896.90K | 41.90K | -112.60K | 109.40K | 923.40K |
| Change in Net Operating Assets | -675.00K | -71.10K | 2.26M | -1.94M | -303.80K |
| Cash from Operations | -1.53M | -1.46M | -56.10K | 208.00K | -2.67M |
| Capital Expenditure | -10.60K | -43.50K | -3.20K | -24.40K | -36.90K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -10.60K | -43.50K | -3.20K | -24.40K | -36.90K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 0.00 | 9.20M | 414.00K | -- | 836.80K |
| Repurchase of Common Stock | -2.80K | -3.50K | -107.10K | -11.30K | -9.80K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 69.70K | -970.00K | -61.70K | -498.10K | 1.72M |
| Cash from Financing | 67.00K | 8.23M | 245.20K | -509.30K | 2.54M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.47M | 6.72M | 185.90K | -325.70K | -159.90K |